Medtronic recalls reflux monitoring devices after capsule failures
Rule ChangesFDA early alert ties 184 serious injuries to Bravo CF delivery device as second recall lands in 14 months
Yesterday: Recall draws broad press coverageNew here? Follow stories to track developments over time. Create a free account to get updates when stories you care about change.
Overview
Updated 2 hours agoThe Bravo CF device attaches a pH-monitoring capsule to the esophagus so doctors can diagnose acid reflux. In 761 reported instances since early 2025, the capsule failed to attach or detach as intended, and 184 of those involved serious injuries.
Medtronic recalled the affected delivery devices in August, and the Food and Drug Administration urged hospitals to quarantine them. Failures can tear the esophagus, block the airway, or leave a foreign object inside the patient. It's the second recall for the same failure in 14 months, though the FDA says the root cause is different this time.
Why it matters
A capsule designed to stick to the esophagus can instead tear it or block the airway — with 184 serious injuries already reported.
Questions about this story
Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.
No questions yet — be the first to ask.
Key Indicators
Voices
Curated perspectives — historical figures and your fellow readers.
Play
Exploring all sides of a story is often best achieved with Play.
Higher or Lower
A number from this story, against one from elsewhere in the news — guess which is bigger, then keep the chain going. 5 rounds, 3 strikes; a miss costs a strike and resets your streak.
Keyboard: ↓/L lower · ↑/H higher
0 points — sign up to put that on the leaderboard.
Connections
Sixteen names from the news. Find the four hidden groups of four. Four mistakes max.
Sign up to keep a daily streak — a new puzzle lands every day.
Exit debate?
Your progress in this debate will be lost.
- 1 Two AI personas square off on this story.
- 2 You predict who'll win each round — correct picks earn XP.
- 3 One crossfire question is yours to fire. Pick it carefully.
Couldn't generate a topic
Select Your Champions
Choose one persona for each side of the debate
DEBATE TOPIC
Choose personas with different perspectives for a more dynamic debate.
Select debater for this side:
No debate personas available right now.
Select debater for this side:
No debate personas available right now.
Who's Got This Round?
Make your prediction before the referee scores
The referee scores both sides on
Round Results
Set the Crossfire
Pick the question both personas must answer in the final round
Debate Oracle! You called every round!
Sharp Instincts! You know your debaters!
The Coin Flip Strategist! Perfectly balanced!
The Contrarian! Bold predictions!
Inverse Genius! Try betting the opposite next time!
XP Breakdown
Prediction History
Organizations Involved
Makes the Bravo pH-monitoring system through its Given Imaging subsidiary.
Regulates medical devices, issues recalls and early alerts, and classifies severity of device problems.
Timeline
June 2025 September 2026
-
Recall draws broad press coverage
Latest MediaFierce Biotech and other outlets report the recall, spreading the FDA alert widely.
-
Injury count hits 184
DataMedtronic reports 184 serious injuries and no deaths to the FDA.
-
Second recall for deployment failure
RecalMedtronic issues second recall letter citing a deployment-component fault; 184 injuries now reported.
-
First recall called Class I
RegulatoryFDA classifies the June 2025 recall as Class I, its most serious device-recall category.
-
FDA issues early alert
RegulatoryFDA notifies the public of a potentially high-risk device issue with Bravo CF delivery devices.
-
Updated recall letter sent
RecalMedtronic sends an updated letter to customers and distributors about the affected devices.
-
First recall over adhesive defect
RecalMedtronic sends URGENT recall letter citing adhesive misapplication during manufacturing; 33 serious injuries reported.
Historical Context
2 moments from history that rhyme with this story — and how they unfolded.
Guidant defibrillator recalls (2005-2006)
Guidant recalled heart defibrillators after discovering short-circuit failures that could stop the devices from delivering lifesaving shocks. The recall began with a narrow set of models and expanded to more.
Guidant faced lawsuits and sharp FDA scrutiny over how it disclosed the failures.
The case set precedents for timely disclosure of device failures to doctors and patients.
Bravo CF mirrors the pattern of repeated recalls for the same underlying device, with the FDA pressing for faster disclosure each time.
Philips Respironics CPAP recall (2021)
Philips recalled millions of CPAP and ventilator devices in June 2021 because sound-abating foam degraded and could be inhaled by patients. The recall expanded over years and drew a consent decree with the FDA in 2024.
Philips set aside billions of dollars for recalls and settled with affected patients; the FDA required a structured remediation plan.
The case shows how a single device failure can cascade into years of regulatory and legal fallout.
Like Philips, Medtronic faces a device whose failure mode harms patients in a way the original design was meant to prevent.
